Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Monday, November 5, 2012

Registry Data Show Hepatitis B Medications Appear Safe during Pregnancy

An analysis of data from the Antiretroviral Pregnancy Registry found no evidence that pregnant women's use of drugs to treat chronic hepatitis B — including lamivudine (Epivir) and tenofovir (Viread) — is associated with birth defects, according to a report in the November 2012 Journal of Hepatology.

Hepatitis B virus (HBV) can be transmitted from mother-to-child during pregnancy or delivery. Treatment with antiviral medications can reduce HBV viral load — and thereby lower the risk of transmission — but caution is warranted when using drugs during pregnancy because some can cause problems including congenital abnormalities.

Read more...

No comments:

Post a Comment